RECOVERY- Tissue Purchase Order Contract Acquisition for NCI's The Cancer Genome Atlas Program

A modification was made to UT-MD Anderson's puchase order HHSN261201000032I to provide 200 additional bladder cases for The Cancer Genome Atlas (TCGA) Program, NIH, NCI.

DUNS:  800772139

This project is funded by the American Recovery and Reinvestment Act (ARRA) of 2009 and is subject to all reporting.

The procurement was classified under the North American Industry Classification System code 325413, size standard 500.

An award was made to Health Research, Inc. DBA Roswell Park in response to the interim due date 06/08/10, to provide multiple tissue types for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 824771034

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with a size standard of 500.

A modification to purchase order HHSN261201000027I was made to MSKCC to provide 6 cases of renal papillary tissues for The Cancer Genome Atlas Program (TCGA), NIH, NCI. 

DUNS: 064931884

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

A modification was made to Mayo Foundation in providing 29 additional renal papillary tissues for The Cancer Genome Atlas (TCGA) Program, National Institutes of Health, National Cancer Institute.  This modification also includes funding for payments 2-4.

DUNS: 006471700

This project is funded by the American Recovery and Reinvestment Act (ARRA) of 2009 and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size standard of 500.

An award was made to the University of Hawaii in response to the 06/20/2010 interim due date, to provide cervical tissue to the existing contract for the Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health.

DUNS: 965088057

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to Memorial Sloan Kettering Cancer Center (MSKCC) in response to the 6/8/10 interim due date, to provide bladder urothelial carcinoma tissues for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 064931884

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

Amendment 3 designates July 20th 2010 as an interim closing date.  August
3rd, 2010 at 3pm is the final closing date for RFQ-NCI-10008-AS. 

An award was made to Cedars-Sinai Medical Center in response to the 6/8/10 interim due date, to provide cervical squamous cell carcinoma tissues with blood normal for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 075307785

This project is funded by the American Recovery and Reinvestment Act (ARRA) of 2009 and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code (NAICS) 325413 with an employee size of 500.

An award was made to Brigham & Women's Hospital  in response to the 04/27/10 interim due date, to provide clear cell renal carcinoma tissues with adjacent and whole blood for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 030811269

This project is funded by the American Recovery and Reinvestment Act (ARRA) of 2009 and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code (NAICS) 325413 with an employee size of 500.

An award was made to the Mayo Foundation in response to the 5/11/10 interim due date, to provide clear cell renal carcinoma tissues for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 006471700

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Indistry Classification System Code 325413 with an employee size of 500.

An award was made to Ontario Institute for Cancer Research in response to the 5/11/10 due date under RFQ-NCI-10008-AS to provide the following: lung tissue for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health

DUNS: 205540219

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to the University of Pittsburgh through a modification to their existing purchase order, HHSN261201000014I, to provide an additional 200 renal clear cell tissues with adjacent normal under CLIN 1 for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 004514360

This project is funded by the American Recovery and Reinvestment Act (ARRA) of 2009 and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to the University of North Carolina through a modification to existing purchase order, HHSN261201000004I, to provide an additional 19 cases of renal clear cell carcinoma and papillary w/a mixture of blood and adjacent normal under CLIN 1 for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 608195277

This project is funded by the American Recovery and Reinvestment Act (ARRA) of 2009 and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to UT-MD Anderson in response to the 03/16/10 interim due date, to provide clear cell renal carcinoma tissues for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 800772139

This project is funded by the American Recovery and Reinvestment Act (ARRA) of 2009 and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to Memorial Sloan Kettering Cancer Center in reponse to the 3/2/10 interim due date, to provide kidney clear cell tissues for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, National Institutes of Health.

DUNS: 064931884

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to the University of Pittsburgh in response to the 12/22/2009 interim due date, to provide renal cell, kidney papillary, cervical, bladder papillary, and bladder non-papillary tissues for The Cancer Genome Atlas (TCGA) Program, National Cancer Institute, the National Institutes of Health.

DUNS: 004514360

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

An award was made to the Medical College of Wisconsin in response to the 02/01/2010 interim due date, to provide uterine (cervical-squamous) tissues for The Cancer Genome Atlas Program, National Cancer Institute, National Institutes of Health.

DUNS: 93-763-9060

This project is funded by the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to all reporting.

The procurement was classified under the North American Industry Classification System Code 325413 with an employee size of 500.

This is a combined synopsis/solicitation for commercial items using simplified acquisition procedures and prepared in accordance with format in FAR 12.6 as supplemented with additional information included in this notice.

The full text of Request for Quotation (RFQ) RFQ-NCI-10008-AS may be accessed through the National Cancer Institute's (NCI) Office of Acquisitions homepage by using the following internet address - http://rcb.cancer.gov/rcb-internet/index.jsp. (Please click on Current Request for Proposals to access). Only electronic copies of the solicitation are available. It is the offeror's responsibility to monitor the above internet site for the solicitation and any amendments. POTENTIAL OFFERORS WILL BE RESPONSIBLE FOR DOWNLOADING THEIR OWN COPY OF THE SOLICITATION AND AMENDMENTS. No collect calls will be accepted.

This project is funded thorough the American Recovery and Reinvestment Act of 2009 (ARRA) and is subject to the reporting requirements of the act.

It is anticipated this solicitation will result in multiple awards.

Awards resulting from this solicitation No. RFQ-NCI-10008-AS will include all applicable provisions and clauses in effect at the time of award for commercial items using simplified procedures.

Under this RFQ, the offeror shall provide clinically annotated biospecimens to TCGA for the following cancer types: Renal cell carcinoma, Prostate adenocarcinoma, Kidney Papillary Carcinoma, Cervical Cancer (squamous), Bladder urothelial carcinoma - nonpapillary, Bladder urothelia carcinoma - papillary, Other Cancer Types Currently Not Identified.

The NCI is expanding its basic and translational research programs that rely heavily on sufficient availability of high quality well annotated biospecimens suitable for use in genomic studies. The NCI's overarching goal with such programs is to improve the ability to diagnose, treat, and prevent cancer. The Cancer Genome Atlas (TCGA), one such program, is a comprehensive and coordinated effort to accelerate our understanding of the molecular basis of cancer through the application of genome analysis technologies. The NCI and the National Human Genome Research Institute (NHGRI) launched TCGA as a 3-year pilot project in 2006, and have since (August 2009) initiated the second phase of the project to study at least 20 additional cancers over 5 years. This project aims to systematically explore the entire spectrum of genomic changes involved in human cancer. Specifically, the project is designed to comprehensively analyze DNA copy number changes, including large (on the order of chromosome segments) and small (1,000-100,000 kb) scale rearrangements, transcription profiles, epigenetic modifications, sequence variation, and sequence in both tumor tissue and case-matched germline DNA. The suite of analysis platforms will be applied to a common set of molecular analytes obtained from clinically annotated high-quality tumor biospecimens and case-matched normal tissue (control). More detailed information can be found at the project's website: http://cancergenome.nih.gov. To successfully generate comprehensive data in phase two, TCGA will need in excess of 40,000 biospecimens over course of the project.